Novartis AG SEC filings NVS
Novartis AG has 1,000 filings in SEC EDGAR's recent list, going back to Apr 27, 2009. Its latest annual report, Form 20-F, was filed on Feb 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Mar 17, 2026 | — |
| FWP | Free writing prospectus | Mar 17, 2026 | — |
| 424B5 | Prospectus supplement | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Feb 4, 2026 | — |
| S-8 POS | Filing | Jan 16, 2026 | — |
| S-8 POS | Filing | Jan 16, 2026 | — |
| S-8 POS | Filing | Jan 16, 2026 | — |
| S-8 POS | Filing | Jan 16, 2026 | — |
| 424B5 | Prospectus supplement | Nov 4, 2025 | — |
| FWP | Free writing prospectus | Nov 4, 2025 | — |
| 424B5 | Prospectus supplement | Nov 3, 2025 | — |
| 424B5 | Prospectus supplement | Sep 17, 2024 | — |
| FWP | Free writing prospectus | Sep 16, 2024 | — |
| 424B5 | Prospectus supplement | Sep 16, 2024 | — |
| F-3ASR | Filing | Sep 16, 2024 | — |
| S-8 POS | Filing | Feb 15, 2024 | — |
| S-8 POS | Filing | Mar 24, 2023 | — |
| S-8 POS | Filing | Jan 10, 2023 | — |
| F-6 POS | Filing | Dec 16, 2022 | — |
| S-8 | Employee stock plan registration | Jul 22, 2021 | — |
| S-8 | Employee stock plan registration | Nov 19, 2020 | — |
| S-8 POS | Filing | Apr 30, 2020 | — |
| S-8 POS | Filing | Apr 30, 2020 | — |
| S-8 POS | Filing | Apr 30, 2020 | — |
| S-8 POS | Filing | Apr 30, 2020 | — |
| 424B5 | Prospectus supplement | Feb 12, 2020 | — |
| FWP | Free writing prospectus | Feb 12, 2020 | — |
| 424B5 | Prospectus supplement | Feb 11, 2020 | — |
| F-3ASR | Filing | Jan 30, 2020 | — |
| S-8 POS | Filing | Mar 15, 2017 | — |
| 424B5 | Prospectus supplement | Feb 15, 2017 | — |
| FWP | Free writing prospectus | Feb 14, 2017 | — |
| 424B5 | Prospectus supplement | Feb 14, 2017 | — |
| 424B5 | Prospectus supplement | Nov 18, 2015 | — |
| FWP | Free writing prospectus | Nov 18, 2015 | — |
| 424B5 | Prospectus supplement | Nov 17, 2015 | — |
| F-3ASR | Filing | Sep 18, 2015 | — |
| S-8 | Employee stock plan registration | Sep 12, 2014 | — |
| F-6EF | Filing | Sep 8, 2014 | — |
| 424B5 | Prospectus supplement | Feb 19, 2014 | — |
| FWP | Free writing prospectus | Feb 18, 2014 | — |
| 424B5 | Prospectus supplement | Feb 18, 2014 | — |
| 424B5 | Prospectus supplement | Sep 19, 2012 | — |
| FWP | Free writing prospectus | Sep 19, 2012 | — |
| 424B5 | Prospectus supplement | Sep 18, 2012 | — |
| F-3ASR | Filing | Sep 18, 2012 | — |
| S-8 | Employee stock plan registration | Apr 8, 2011 | — |
| 424B3 | Prospectus | Feb 28, 2011 | — |
| F-4/A | Amendment no.3 to form f-4 | Feb 24, 2011 | — |
| F-4/A | Amendment no.2 to form f-4 | Feb 17, 2011 | — |
| F-4/A | Amendment no.1 to form f-4 | Feb 2, 2011 | — |
| S-8 | Employee stock plan registration | Jan 18, 2011 | — |
| F-4 | Form f-4 | Dec 23, 2010 | — |
| 424B5 | Prospectus supplement | Mar 10, 2010 | — |
| FWP | Free writing prospectus | Mar 10, 2010 | — |
| 424B5 | Prospectus supplement | Mar 9, 2010 | — |
| S-8 | Employee stock plan registration | Oct 29, 2009 | — |
| F-6EF | Filing | Oct 29, 2009 | — |
Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVS (NYSE), NVSEF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Basel, Switzerland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1114448
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.